Evidence map›Paper›PMID 41634821›Full record

ReviewChinese medicine2026

Natural products and their derivatives as candidate treatments for hair greying: from drug discovery to molecular mechanisms.

Chaoying Zhu, Yuan Gao, Haiying Gong, Jiabo Wang

Abstract readReview
In one paragraph

Review in Chinese medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chaoying Zhu *School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Yuan Gao *School of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, China.
Haiying GongSchool of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, China. haiying@ccmu.edu.cn.
Jiabo WangSchool of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, China. jiabo_wang@ccmu.edu.cn.

Funding

National Science Foundation 82504878
6 · The paper itself

Abstract

ethnopharmacological relevanceHair greying is a common aspect of the natural ageing process. Although it is generally not considered a medical problem, its high prevalence can substantially impact emotional state due to aesthetic concerns. A growing body of research has demonstrated that natural products and their derivatives derived from plants possess advantages and potential in the treatment of hair greying. AIM OF THE STUDY: To review the last research progress in the treatment of hair greying by natural products and their derivatives, focusing on the target and mechanism of action of natural products and their derivatives and providing a reference for future clinical use. MATERIALS AND

methodsWe searched electronic databases (PubMed, Web of Science, ClinicalTrials.gov, and CNKI) for studies published between January 2005 and June 2025. The research focused on the pathogenesis of hair greying and the use of natural products and their derivatives to prevent and treat it, using the keywords: "hair greying", "hair pigmentation", "white hair", "snow hair", "melanocyte stem cells" and "melanin".

resultsAccount of natural products (e.g., Polygoni multiflori radix) and their derivatives (e.g., Epimedin B), are expected to treat hair greying due to their various qualities to regulate melanocyte stem cells, enhance melanin synthesis, or promote melanosome transport. Compared to oral administration, topical application represents a preferred approach for promoting hair pigmentation.

conclusionsWe discussed and summarized the mechanism of natural products and derivatives in the treatment of hair greying, which provided a reference for future clinical use.

Indexed as

DerivativesHair greyingMelanin synthesisMelanocyte stem cellsNatural products

Identifiers

PMID41634821
PMCPMC12866018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.